IMVT - Balance Sheet - Immunovant, Inc.

Current Liabilities	48.6 M
Accounts Payable	7.16 M
Short-Term Debt	138 K
Other Current Liabilities	41.3 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019	Mar-2018
ASSETS
Cash & Cash Equivalents	635.4	376.5	493.8	400.1	100.6	0.3	0
Short Term Investments	0	0	0	0	0	0	0
Receivables	5.5	0.9	12.9	1.1	3.0	0	0
Inventory	0	0	0	0	0	0	0
Other Current Assets	24.9	26.9	6.3	7.7	5.5	0	0.1
Total Current Assets	665.8	404.3	512.9	409.0	109.1	0.3	0.1
PP&E	0.6	1.5	2.6	3.5	65 K	54	0
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0
Other Long Term Assets	0	0	0	0	0.2	79.9 K	0
Other Assets	0	0	0	0	0	0	0
Total Assets	666.4	405.8	515.6	412.5	109.4	0.4	0.1
LIABILITIES
Accounts Payable	7.2	1.4	18.6	2.4	1.2	206	1.1
Short Term Debt	0.1	1.2	1.1	2.4	3.2	0.3	0
Other Current Liabilities	41.3	40.8	24.7	14.0	10.9	80.2 K	0.5
Total Current Liabilities	48.6	43.3	44.5	18.8	15.3	0.4	1.6
Long Term Debt	0	47 K	1.2	2.2	0	0	0
Deferred Tax Income	0.3	0	0	0	0	0	0
Other Liabilities	(0.3)	0	0	0	0	0	0
Total Liabilities	48.6	43.3	45.7	21.0	15.3	0.4	1.6
EQUITY
Common Stock	14 K	13 K	12 K	10 K	5 K	288	0
Retained Earnings	(104.7)	(78.2)	(50.7)	(30.1)	(18.4)	(14.8)	(0.1)
Other Accumulative Comprehensive Income/Loss	0.7	52.8	(0.5)	(0.3)	2.8	1.6	70.8 K
Total Equity	32.1	37.1	22.4	27.0	20.8	(11.9)	0.3
Total Liabilities and Equity	86.6	64.5	43.8	40.0	21.9	0.4	0.4
SHARES OUTSTANDING
Common Shares Outstanding	191.2	178.1	178.2	42.6	101.8	41.8	7.9

Free